Ret Proto-Oncogene Antikörper (N-Term)
(1 reference)-
- Target Alle Ret Proto-Oncogene (RET) Antikörper anzeigen
- Ret Proto-Oncogene (RET)
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of RET.
- Kreuzreaktivität
- Human
- Immunogen
- A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human RET.
- Top Product
- Discover our top product RET Primärantikörper
-
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibody
RET Reaktivität: Human IHC, StM Wirt: Maus Monoclonal RET-2795 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 1-1072) antibodyRET Reaktivität: Human WB, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibodyRET Reaktivität: Human ELISA, Coat Wirt: Maus Monoclonal RET-2663 unconjugated
anti-Ret Proto-Oncogene (RET) antibodyRET Reaktivität: Human WB Wirt: Kaninchen Monoclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 152-182), (N-Term) antibodyRET Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB00705 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 1012-1042), (C-Term) antibodyRET Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB01561 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 361-458) antibodyRET Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1A5 unconjugated
anti-Ret Proto-Oncogene (RET) (C-Term) antibodyRET Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (pTyr1062) antibodyRET Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 29-300) antibodyRET Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:50-100)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In PBS (0.09 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "In vitro formation of enteric neural network structure in a gut-like organ differentiated from mouse embryonic stem cells." in: Stem cells (Dayton, Ohio), Vol. 24, Issue 6, pp. 1414-22, (2006) (PubMed).
-
: "In vitro formation of enteric neural network structure in a gut-like organ differentiated from mouse embryonic stem cells." in: Stem cells (Dayton, Ohio), Vol. 24, Issue 6, pp. 1414-22, (2006) (PubMed).
-
- Target
- Ret Proto-Oncogene (RET)
- Andere Bezeichnung
- RET (RET Produkte)
- Synonyme
- c-ret antikoerper, cret antikoerper, etID315074.13 antikoerper, ret1 antikoerper, wu:fd13h01 antikoerper, X-ret antikoerper, ret-A antikoerper, xret antikoerper, RET antikoerper, MTC1 antikoerper, CDHF12 antikoerper, CDHR16 antikoerper, HSCR1 antikoerper, MEN2A antikoerper, MEN2B antikoerper, PTC antikoerper, RET-ELE1 antikoerper, RET51 antikoerper, RET9 antikoerper, c-Ret antikoerper, ret proto-oncogene receptor tyrosine kinase antikoerper, ret proto-oncogene S homeolog antikoerper, ret proto-oncogene antikoerper, ret antikoerper, ret.S antikoerper, RET antikoerper, Ret antikoerper
- Gen-ID
- 5979
- Pathways
- RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-
